Details: 60 min web-assisted phone interview Please sign up at the link below to receive an email invite to the survey. Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …
Rare Patient Voice: Research opportunity for Pancreatic or Endometrial cancer patients and caregivers
Details: 15 min online survey Please sign up at the link below to receive an email invite to the survey. Compensation $25 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay …
Rare Patient Voice: Research opportunity for Endometrial Cancer, Renal Cell Carcinoma, or Liver Cancer patients that are advanced/metastatic 1L or 2L.
Details: 60 min web-assisted phone interview Please sign up at the link below to receive an email invite to the survey. Compensation $100 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to …
Jemperli
From: breastcancer.org Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available. Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy. How Jemperli works …
Savvy Cooperative: Endometrial Cancer Patients (or their Caregivers) Experienced with the Combination Treatment of Keytruda and Lenvima
SCREENER Eligibility Criteria: Have been diagnosed with endometrial cancer Proof of diagnosis will be required to participate Participant has experience with combination treatment of Keytruda and Lenvima. US Residents Details: 60-minute to 90-minute interviews Receive: $100-$150 Link: https://gigs.savvy.coop/endometrial/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating better products and services, that companies and researchers will pay …
Rare Patient Voice: Study Opportunity for Endometrial Cancer Patients
Study Details: 60 min Web-Assisted Interview followed by a 30-minute survey US patients only Compensation $200 upon completion of both (both must be completed) Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences? We connect …
In first, cancer drugs simultaneously approved in US, Canada, Australia
From: biopharmadive.com For the first time, regulators in the U.S., Australia and Canada on Tuesday simultaneously approved two cancer drugs via a project led by the Food and Drug Administration’s oncology center. Merck & Co.’s immunotherapy Keytruda, when paired with Merck and Eisai’s Lenvima, is now cleared to treat certain endometrial tumors, a decision that expands the labels for both …
New Guidelines Provide Vital Information for Women Diagnosed with the Most Common Type of Gynecologic Cancer
NCCN Guidelines for Patients: Uterine Cancer — published during Gynecologic Cancer Awareness Month — explains treatment options and raises awareness While the number of deaths from most cancers is on the decline in the United States, it is rising for the most common type of uterine cancer—endometrial cancer. The newest NCCN Guidelines for Patients® focuses on uterine cancers (endometrial cancer …
ONC201 Trial Begins for Endometrial and Breast Cancer
Oncoceutics, Inc. announced today that the first patient has been treated in a clinical trial of ONC201 for patients with certain types of advanced endometrial and breast cancer. The Phase II trial is led by Alexandra Zimmer, MD, Assistant Research Physician at the Women’s Malignancies Branch at the National Cancer Institute (NCI) Center for Cancer Research, part of the National …
Increased Endometrial Cancer Rates Found in Women with High Levels of Cadmium
More than 31,000 new cases of endometrial cancer are expected to be diagnosed in 2017. Through a five-year observational study recently published in PLOS One, researchers at the University of Missouri found that women with increased levels of cadmium — a metal commonly found in foods such as kidneys, liver and shellfish as well as tobacco — also had an …
- Page 1 of 2
- 1
- 2